Latest Headlines

  1. Contego Medical’s Peripheral Balloon Angioplasty System Earns CE Mark Approval
    4/27/2017

    Contego Medical, LLC announced today that it has received CE Marking of its Vanguard IEP™ Peripheral Balloon Angioplasty System with Integrated Embolic Protection.

  2. Samsung GC70 Digital Radiography System Receives FDA 510(k) Clearance
    4/26/2017

    Samsung, an emerging leader in medical imaging technology, announces that the GC70 Digital Radiography (DR) system received FDA 510(k) clearance for the U.S. market, underscoring the company’s commitment to expanding its suite of radiography products.

  3. Could Ingestible Sensors Replace Colonoscopies?
    4/26/2017

    A team of Australian scientists has just completed a phase one human clinical trial with an ingestible biosensor that can measure gas produced by the gut, and potentially transmit results to a connected smartphone. 

  4. Philips Off To Solid Start In 2017, Expects Growth To Accelerate
    4/26/2017

    Philips' HealthTech portfolio powered the company's first quarter performance, and growth is expected to accelerate through 2017, despite weakness in the United States market related to potential healthcare policy changes.

  5. Intuitive Surgical’s da Vinci X System Gains CE Mark Approval
    4/26/2017

    Intuitive Surgical, a global technology leader in robotic-assisted, minimally invasive surgery, announced today that its new da Vinci X Surgical System received CE Mark approval in Europe.

  6. joimax’s Spinal Surgery Device Cleared By FDA
    4/26/2017

    joimax, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, recently announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Endovapor 2 Multi Radio Frequency System.

  7. Becton Dickinson Diversifies Via $24 Billion C.R. Bard Acquisition
    4/25/2017

    Becton Dickinson (BD) is paying $24 billion in cash and stock to acquire C. R. Bard to move beyond diabetes care and into peripheral vascular disease, urology, hernia, and cancer treatments, as well as to round out its market-leading medication management portfolio.

  8. GE Beats Q1 Forecasts On Strength Of Double-Digit Growth In Healthcare Equipment
    4/25/2017

    GE continues to report “solid” performance for its healthcare sector, despite what CEO Jeffrey Immelt called “slow growth in a volatile environment” and challenges in other segments

  9. Allergan Gets FDA OK To Market Neurostimulator That Temporarily Increases Tear Production
    4/25/2017

    Allergan plc, (NYSE: AGN) today announced that it has been granted marketing authorization from the U.S. Food and Drug Administration (FDA) for TrueTear™ Intranasal Tear Neurostimulator, the first and only FDA-cleared device developed to temporarily increase tear production during neurostimulation in adult patients.Allergan plc, (NYSE: AGN) today announced that it has been granted marketing authorization from the U.S. Food and Drug Administration (FDA) for TrueTear™ Intranasal Tear Neurostimulator, the first and only FDA-cleared device developed to temporarily increase tear production during neurostimulation in adult patients.

  10. Danaher CEO Expects Acquisitions, R&D To Fuel Long-Term Growth
    4/24/2017

    Danaher Corporation's recent acquisitions, reinvestments, and the Chinese market will continue to help drive long-term growth, according to the company's CEO, Thomas P. Joyce, Jr.